Martin Steven Robert 4
4 · AmpliPhi Biosciences Corp · Filed Sep 11, 2017
Insider Transaction Report
Form 4
Martin Steven Robert
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-09-07+139,000→ 139,000 totalExercise: $0.91Exp: 2027-09-06→ Common Stock (139,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option vest on September 7, 2018. The remainder of the shares vest in equal monthly installments thereafter over the next three years.